Centre Hospitalier Universitaire de la Guadeloupe
Pointe-à-Pitre, Guadeloupe, 97159
Location status: Recruiting
Location contact
Eunice NUBRET
CONTACT
Jacqueline DELOUMEAUX, Doctor
PRINCIPAL_INVESTIGATOR
Valérie SOTER
CONTACT
NCT Number: NCT07251036
The French West Indies (Guadeloupe, Martinique) are characterized by a major use of pesticides in bananas plantation from the 1950s. These crops used organochlorine insecticides and especially chlordecone (CLD) from 1972 to 1993. The lack of biotic and abiotic degradation of CLD led to persistent soil pollution, contamination of surface and deep waters, of numerous plant and animal, and of the population. The extent and persistence of CLD contamination over time is a major issue for these territories. An internal reference value (0.4μg/l) was recently determined. Although useful for a population approach, it must be used with caution for the interpretation of an individual result. In response to the strong social demand expressed by the population for access to free chlordecone blood tests, a screening program for blood chlordecone test was authorized by the 2019 French Finance Act.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Pointe-à-Pitre, Guadeloupe, 97159
Location status: Recruiting
Eunice NUBRET
CONTACT
Jacqueline DELOUMEAUX, Doctor
PRINCIPAL_INVESTIGATOR
Valérie SOTER
CONTACT
The target populations will receive an invitation letter with an information notice and a consent form. The referral physician will explain the program and the research project and prescribe a standardized blood sample test.
Blood samples will be taken in one of the biology laboratories participating in the project. Serum chordecone test will be performed by the Pasteur Institute of Guadeloupe. Blood samples for biological collection will be sent to the Biological Resource Center, Karubiotec™. The result of the chlordécone level will be sent back to each subject with a recommendation note based on the chlordécone level value. Phone contact information for those who consented to the study will be forwarded to the research assistant for the questionnaire.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Exclusion criteria
The target populations will receive an invitation letter with an information notice and a consent form. The referral physician will explain the program and the research project and prescribe a standardized blood sample test.
Blood samples will be taken in one of the biology laboratories participating in the project. Serum chordecone test will be performed by the Pasteur Institute of Guadeloupe. Blood samples for biological collection will be sent to the Biological Resource Center, Karubiotec™. The result of the chlordécone level will be sent back to each subject with a recommendation note based on the chlordécone level value. Phone contact information for
Time frame: between Day0 to Day15
ug/l
Time frame: between day 15 and day 45 ,
chlordeconemia survey
Time frame: At 9 months after intervention
ug/l
Time frame: At 18 months after intervention
ug/l
Time frame: at delivery for pregnant women
ug/l
Time frame: between day 15 to day 45, at month 9 and month 18
chlordeconemia survey
Contact information is provided by the study sponsor or research team.
Eunice NUBRET
CONTACT
Valérie HAMONY-SOTER
CONTACT
Centre Hospitalier Universitaire de la Guadeloupe
Other
Acronym: ChlorGua
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.